The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bevacizumab-based therapy in patients with heavily pretreated ovarian and other Mullerian tract cancers.
Jutta Anna Kurbacher
No relevant relationships to disclose
Jutta Lepique
No relevant relationships to disclose
Susanne Herz
No relevant relationships to disclose
Gabriele Wessling
No relevant relationships to disclose
Christian M. Kurbacher
No relevant relationships to disclose